Levilimab
- Generic Name
- Levilimab
- Drug Type
- Biotech
- CAS Number
- 2035008-70-7
- Unique Ingredient Identifier
- P7UV3L2H80
- Background
Levilimab is under investigation in clinical trial NCT04227366 (Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath